MarketResearchReports.Biz

Pharmaceutical Market: Cameroon-Market Growth, Trends, Size, Share and Forecast

New Market Research Report Added in MarketResearchReports.Biz Reports Database:Pharmaceutical Market: Cameroon

 
Repost This

Albany, NY -- (SBWIRE) -- 05/20/2014 -- Cameroon Pharmaceuticals & Healthcare Report

Cameroon will continue to be one of the least attractive countries in the Middle East and Africa region considering that healthcare provision is not one of the government's key focuses. Consequently, poor healthcare services coupled with other risks such as rampant corruption, approval delays and low percapita healthcare and pharmaceutical expenditure meant little growth opportunities for pharmaceutical investors.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/the-pharmaceutical-market-cameroon

Headline Expenditure Projections

Pharmaceuticals: XAF134.37bn (US$260mn) in 2012 to XAF144.07bn (US$270mn) in 2013; +7.2% in local currency terms and +5.5% in US dollar terms.
Healthcare: XAF698.97bn (US$1.35bn) in 2012 to XAF745.18bn (US$1.42bn) in 2013; +6.6% in local currency terms and 4.9% in US dollar terms.

Risk/Reward Ratings:

Cameroon's Pharmaceutical Risk/Reward Rating (RRR) score for Q213 is unchanged from the previous quarter. This is also the case for all other countries in BMI's proprietary system that ranks pharmaceutical markets according to attractiveness to multinational drugmakers. A minor re-weighting of one of the RRR components is being implemented to improve the tool, and the adjusted scores for all markets will be published in the Q313 updates of the Pharmaceuticals & Healthcare reports. Cameroon has a RRR score of 31.5 out of 100, making it the 27th most attractive pharmaceutical market in the Middle East and Africa.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/198479

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Table of Contents

BMI Industry View7
SWOT9
Political9
Economic10
Business Environment11
Industry Forecast12
Pharmaceutical Market Forecast12

Table: Pharmaceutical Sales Indicators, 2009-201713

Key Growth Factors - Healthcare14

Table: Healthcare Expenditure Indicators, 2009-201717
Table: Healthcare Governmental Indicators, 2009-201718
Table: Healthcare Private Indicators, 2009-201718

Economic Outlook18
Industry Risk Reward Ratings22

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/198479

Table: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q21322

Rewards23
Risks23
Market Overview25
Regulatory Development27
Regulatory Regime27
Competitive Landscape28
Industry And Company Developments28
Demographic Forecast30
Cameroon30

Table: Cameroon\'s Population By Age Group, 1990-2020 (\'000)31
Table: Cameroon\'s Population By Age Group, 1990-2020 (% of total)31
Table: Cameroon\'s Key Population Ratios, 1990-202032
Table: Cameroon\'s Rural And Urban Population, 1990-202033

Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz